{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:06:48Z","timestamp":1793232408036,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ebiom.2024.105068","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T07:53:38Z","timestamp":1711094018000},"page":"105068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8427-9755","authenticated-orcid":false,"given":"Ilanah J.","family":"Pruis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jan","family":"van Doormaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger K.","family":"Balvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"van den Bent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita A.","family":"Harteveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda C.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Segbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelf","family":"Valkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik A.","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-0977","authenticated-orcid":false,"given":"Sophie E.M.","family":"Veldhuijzen van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2024.105068_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105068_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031029","article-title":"The added value of diagnostic and theranostic PET imaging for the treatment of CNS tumors","volume":"21","author":"Pruis","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105068_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105068_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5358545","article-title":"Prostate-specific membrane antigen as target for neuroimaging of central nervous system tumors","volume":"2022","author":"Stopa","year":"2022","journal-title":"Mol Imaging"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105068_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00234-021-02828-2","article-title":"Ga-68 PSMA PET\/CT in recurrent high-grade gliomas: evaluating PSMA expression in\u00a0vivo","volume":"64","author":"Kumar","year":"2022","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ebiom.2024.105068_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.980058","article-title":"[(68)Ga]Ga-PSMA PET\/MRI, histological PSMA expression and preliminary experience with [(177)Lu]Lu-PSMA therapy in relapsing high-grade glioma","volume":"12","author":"Truckenmueller","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41598-021-04613-w","article-title":"Expression of glutamate carboxypeptidase II in the glial tumor recurrence evaluated in\u00a0vivo using radionuclide imaging","volume":"12","author":"Kunikowska","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105068_bib8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00259-020-04715-z","article-title":"Tumor uptake in glioblastoma multiforme after IV injection of [(177)Lu]Lu-PSMA-617","volume":"47","author":"Kunikowska","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105068_bib9","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1097\/RLU.0000000000003142","article-title":"177Lu-\/68Ga-PSMA theranostics in recurrent glioblastoma multiforme: proof of concept","volume":"45","author":"Kumar","year":"2020","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105068_bib10","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1097\/RLU.0000000000004612","article-title":"Short-interval, low-dose [ 177 Lu]Lu-Prostate-Specific membrane antigen in the treatment of refractory glioblastoma","volume":"48","author":"More","year":"2023","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105068_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2967\/jnumed.122.264850","article-title":"[(177)Lu]Lu-PSMA therapy as an individual treatment approach for patients with high-grade glioma: dosimetry results and critical statement","volume":"64","author":"Graef","year":"2023","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105068_bib12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2967\/jnumed.117.191395","article-title":"Targeted alpha-therapy of metastatic castration-resistant prostate cancer with (225)Ac-PSMA-617: dosimetry estimate and empiric dose finding","volume":"58","author":"Kratochwil","year":"2017","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105068_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/RLU.0000000000001763","article-title":"Combination of 177Lu-PSMA-617 and external radiotherapy for the treatment of cerebral metastases in patients with castration-resistant metastatic prostate cancer","volume":"42","author":"Wei","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105068_bib14","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s00259-019-04354-z","article-title":"Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617","volume":"46","author":"Sathekge","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ebiom.2024.105068_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.950167","article-title":"A\u00a0systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: the state-of-the-art","volume":"12","author":"Pinkiewicz","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105068_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-020-03435-6","article-title":"Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going","volume":"147","author":"D'Amico","year":"2020","journal-title":"J\u00a0Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105068_bib17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1148\/radiol.2433060536","article-title":"Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients","volume":"243","author":"Kaufmann","year":"2007","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105068_bib18","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00259-020-05096-z","article-title":"Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [(68)Ga]DOTATATE","volume":"48","author":"Veldhuijzen van Zanten","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105068_bib19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105068_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","article-title":"Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0","volume":"46","author":"Law","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib21","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/RLU.0000000000001451","article-title":"Diagnostic value of 68Ga PSMA-11 PET\/CT imaging of brain tumors-preliminary analysis","volume":"42","author":"Sasikumar","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105068_bib22","article-title":"Salivary gland toxicity of PSMA-targeted radioligand therapy with (177)Lu-PSMA and combined (225)Ac- and (177)Lu-labeled PSMA ligands (TANDEM-PRLT) in advanced prostate cancer: a single-center systematic investigation","volume":"12","author":"Langbein","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105068_bib23","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","article-title":"EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands","volume":"49","author":"Sj\u00f6green Gleisner","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-019-0211-y","article-title":"Intra-individual comparison of (68)Ga-PSMA-11 and (18)F-DCFPyL normal-organ biodistribution","volume":"19","author":"Ferreira","year":"2019","journal-title":"Cancer Imag"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105068_bib25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105068_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13550-017-0339-3","article-title":"IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms","volume":"7","author":"Andersson","year":"2017","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroimage.2010.07.033","article-title":"Unbiased average age-appropriate atlases for pediatric studies","volume":"54","author":"Fonov","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1109\/TMI.2009.2035616","article-title":"elastix: a toolbox for intensity-based medical image registration","volume":"29","author":"Klein","year":"2010","journal-title":"IEEE Trans Med Imaging"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105068_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1470-2045(19)30098-1","article-title":"Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study","volume":"20","author":"Kickingereder","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105068_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41592-020-01008-z","article-title":"nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation","volume":"18","author":"Isensee","year":"2021","journal-title":"Nat Methods"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105068_bib32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1109\/TMI.2004.830803","article-title":"Performance-based classifier combination in atlas-based image segmentation using expectation-maximization parameter estimation","volume":"23","author":"Rohlfing","year":"2004","journal-title":"IEEE Trans Med Imaging"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105068_bib33","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage"},{"issue":"supplement 1","key":"10.1016\/j.ebiom.2024.105068_bib34","first-page":"1128","article-title":"Characterization of the receptor binding kinetics of PSMA-specific peptides by surface plasmon resonance spectroscopy","volume":"59","author":"Gordon","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13550-020-0594-6","article-title":"Kinetic modeling of (68)Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients","volume":"10","author":"Ringheim","year":"2020","journal-title":"EJNMMI Res"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105068_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2967\/jnumed.121.261906","article-title":"Tumor sink effect in (68)Ga-PSMA-11 PET: myth or reality?","volume":"63","author":"Gafita","year":"2022","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105068_bib37","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","article-title":"Joint EANM\/SNMMI procedure guideline for the use of (177)Lu-labeled PSMA-targeted radioligand-therapy ((177)Lu-PSMA-RLT)","volume":"50","author":"Kratochwil","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105068_bib38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105068_bib39","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00259-016-3424-3","article-title":"Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer","volume":"43","author":"Pfob","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105068_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/RLU.0000000000004716","article-title":"Discriminating inflammatory radiation-related changes from early recurrence in patients with glioblastomas: a preliminary analysis of 68 Ga-PSMA-11 PET\/CT compared with 18 F-FDOPA PET\/CT","volume":"48","author":"Moreau","year":"2023","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imag"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105068_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13550-020-00642-0","article-title":"High uptake of (68)Ga-PSMA and (18)F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes","volume":"10","author":"Oliveira","year":"2020","journal-title":"EJNMMI Res"},{"issue":"Suppl 3","key":"10.1016\/j.ebiom.2024.105068_bib43","doi-asserted-by":"crossref","first-page":"iii93","DOI":"10.1093\/annonc\/mdu050","article-title":"High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Stupp","year":"2014","journal-title":"Ann Oncol"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105068_bib44","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.7150\/thno.56639","article-title":"A\u00a0perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma","volume":"11","author":"Bolcaen","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105068_bib45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","article-title":"68Ga- and 177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies","volume":"56","author":"Weineisen","year":"2015","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105068_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123020","article-title":"Pharmacological optimization of PSMA-based radioligand therapy","volume":"10","author":"van der Gaag","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105068_bib47","first-page":"471","article-title":"Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy","volume":"21","author":"Chow","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105068_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma - taking the fight to the tumour","volume":"18","author":"van Solinge","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105068_bib49","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1007\/s00259-022-05925-3","article-title":"[(89)Zr]Zr-PSMA-617 PET\/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates","volume":"49","author":"Rosar","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T14:05:26Z","timestamp":1737986726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":49,"alternative-id":["S2352396424001038"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105068","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105068"}}